Artivion, Inc. (AORT) stock

AORTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 8/3023% above fair value

$19.40−0.70 (-3.48%)

Close on Nov 12, 2026Market cap $945.87MP/E –Yield –

Artivion EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Artivion's EV/EBITDA was 28.3× on Nov 11, 2026, against 44.8× a year earlier. Over the last 5 years it ranged from 19.8× to 50.5×, with a median of 32.6×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	28.3×	−15.6
2025	Dec 31, 2025	43.9×	+20.3
2024	Dec 31, 2024	23.6×	−10.9
2023	Dec 29, 2023	34.5×	−13.0
2022	Dec 30, 2022	47.6×	+23.0
2021	Dec 31, 2021	24.5×	−21.9
2020	Dec 31, 2020	46.4×	+11.5
2019	Dec 31, 2019	34.9×	−18.0
2018	Dec 31, 2018	52.9×	+23.1
2017	Dec 29, 2017	29.9×	+8.5
2016	Dec 30, 2016	21.4×	−9.5
2015	Dec 31, 2015	30.9×	+12.7
2014	Dec 31, 2014	18.2×	+2.8
2013	Dec 31, 2013	15.4×	+6.3
2012	Dec 31, 2012	9.1×	−0.1
2011	Dec 30, 2011	9.2×	+2.6
2010	Dec 31, 2010	6.6×	–